Orpheus Bioscience, Inc. — Form D/A
Orpheus Bioscience, Inc. of MANASSAS, VA, a company, filed a Form D amendment with the SEC on 2017-06-07. The offering totals $1.6M, of which $1.3M was reported sold. Industry: Other.
Offering
- Filed: 2017-06-07
- Form: D/A
- Accession: 0001707212-17-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $1.6M
- Amount sold: $1.3M
- Remaining: $345K
- Investors: 20
- Date of first sale: 2017-05-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-287202
Issuer
- Name: Orpheus Bioscience, Inc.
- CIK: 0001707212
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 9385 DISCOVERY BLVD. #115, MANASSAS, VA, 20109
- Phone: (212) 692-6758
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Guy Yachin | Director | Aurora, CO |
| Guy Yachin | Executive Officer | Aurora, CO |
| Cohava Gelber | Director | Manassas, VA |
| John Abeles | Director | Manassas, VA |
Other filings by this issuer (3)
More